Goldman Sachs’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.2M Buy
1,725,529
+65,018
+4% +$798K ﹤0.01% 1739
2025
Q1
$36.5M Buy
1,660,511
+35,790
+2% +$787K 0.01% 1256
2024
Q4
$36.8M Buy
1,624,721
+318,203
+24% +$7.22M 0.01% 1304
2024
Q3
$23.7M Buy
1,306,518
+701,397
+116% +$12.7M ﹤0.01% 1608
2024
Q2
$17.6M Buy
605,121
+12,009
+2% +$350K ﹤0.01% 1674
2024
Q1
$21M Sell
593,112
-59,042
-9% -$2.09M ﹤0.01% 1513
2023
Q4
$28.4M Sell
652,154
-31,139
-5% -$1.36M 0.01% 1315
2023
Q3
$26.1M Buy
683,293
+70,105
+11% +$2.68M 0.01% 1318
2023
Q2
$25.2M Sell
613,188
-188,902
-24% -$7.77M 0.01% 1385
2023
Q1
$46M Sell
802,090
-316,288
-28% -$18.2M 0.01% 964
2022
Q4
$62.7M Buy
1,118,378
+140,707
+14% +$7.89M 0.02% 829
2022
Q3
$41.4M Sell
977,671
-488,541
-33% -$20.7M 0.01% 1081
2022
Q2
$79.2M Sell
1,466,212
-53,531
-4% -$2.89M 0.02% 721
2022
Q1
$97.7M Buy
1,519,743
+37,025
+2% +$2.38M 0.02% 673
2021
Q4
$99.3M Buy
1,482,718
+629,202
+74% +$42.2M 0.02% 702
2021
Q3
$58.4M Sell
853,516
-27,554
-3% -$1.89M 0.01% 1008
2021
Q2
$60.1M Buy
881,070
+86,991
+11% +$5.94M 0.01% 945
2021
Q1
$54.9M Buy
794,079
+239,762
+43% +$16.6M 0.01% 982
2020
Q4
$36M Sell
554,317
-190,774
-26% -$12.4M 0.01% 1174
2020
Q3
$35.2M Buy
745,091
+83,427
+13% +$3.94M 0.01% 1099
2020
Q2
$31.1M Sell
661,664
-324,459
-33% -$15.2M 0.01% 1178
2020
Q1
$44.1M Buy
986,123
+280,818
+40% +$12.5M 0.02% 868
2019
Q4
$41.1M Buy
705,305
+392,285
+125% +$22.9M 0.01% 1152
2019
Q3
$18.8M Buy
313,020
+12,176
+4% +$731K 0.01% 1562
2019
Q2
$16.8M Buy
300,844
+40,759
+16% +$2.28M ﹤0.01% 1683
2019
Q1
$14.5M Sell
260,085
-42,534
-14% -$2.37M ﹤0.01% 1805
2018
Q4
$13.6M Buy
302,619
+32,061
+12% +$1.45M ﹤0.01% 1763
2018
Q3
$17.8M Sell
270,558
-747,738
-73% -$49.3M ﹤0.01% 1717
2018
Q2
$65.6M Sell
1,018,296
-104,227
-9% -$6.71M 0.02% 922
2018
Q1
$62.1M Buy
1,122,523
+64,816
+6% +$3.59M 0.02% 941
2017
Q4
$50.6M Sell
1,057,707
-80,983
-7% -$3.88M 0.01% 1081
2017
Q3
$57.5M Sell
1,138,690
-51,180
-4% -$2.58M 0.01% 985
2017
Q2
$64.9M Buy
1,189,870
+101,092
+9% +$5.51M 0.02% 900
2017
Q1
$45.9M Sell
1,088,778
-123,166
-10% -$5.19M 0.01% 1058
2016
Q4
$52M Buy
1,211,944
+96,188
+9% +$4.13M 0.01% 977
2016
Q3
$46.1M Sell
1,115,756
-212,504
-16% -$8.77M 0.01% 1023
2016
Q2
$53M Sell
1,328,260
-67,864
-5% -$2.71M 0.02% 878
2016
Q1
$47M Buy
1,396,124
+117,020
+9% +$3.94M 0.02% 935
2015
Q4
$43.3M Sell
1,279,104
-73,062
-5% -$2.48M 0.01% 973
2015
Q3
$40.3M Buy
1,352,166
+1,122,550
+489% +$33.4M 0.01% 921
2015
Q2
$6.32M Sell
229,616
-1,566,212
-87% -$43.1M ﹤0.01% 1943
2015
Q1
$45.3M Sell
1,795,828
-168,491
-9% -$4.25M 0.01% 907
2014
Q4
$43.5M Buy
1,964,319
+388,989
+25% +$8.62M 0.01% 894
2014
Q3
$32M Buy
1,575,330
+596,352
+61% +$12.1M 0.01% 1023
2014
Q2
$18.8M Buy
978,978
+971,093
+12,316% +$18.7M 0.01% 1294
2014
Q1
$148K Sell
7,885
-143,260
-95% -$2.69M ﹤0.01% 4049
2013
Q4
$2.95M Buy
151,145
+77,242
+105% +$1.51M ﹤0.01% 2359
2013
Q3
$1.22M Buy
73,903
+12,670
+21% +$208K ﹤0.01% 2824
2013
Q2
$917K Buy
+61,233
New +$917K ﹤0.01% 2846